Abstract: Guide systems for installing aircraft structures are disclosed. An example apparatus includes a first guide system structured to removably couple to a first aircraft structure having a first hinge component. A second guide system is structured to removably couple to a second aircraft structure having a second hinge component. The first guide system is to engage the second guide system to enable alignment between the first hinge component and the second hinge component during assembly of the first aircraft structure and the second aircraft structure.

Abstract: A Dectin-2 ligand vaccine adjuvant and a method of making and using the Dectin-2 ligand vaccine adjuvant in a vaccine to immunize a patient are disclosed. Also discloses is a vaccine composition comprising a Bl-Eng2 antigen and methods of using the vaccine composition to immunize a subject against a fungal infection.

Abstract: Methods and apparatuses for presenting menus to DVR users and users of other media playback devices are described. After a DVR (or other media device) has finished playing a recorded television program (or other content), or in response to other specified events, the DVR presents a screen which comprises a menu. In addition to or in alternative to “save” and “delete” options, the menu comprises one or more options. Each of these other options may correspond to a separate item. For example, a user's selection of such an option may cause the DVR to display or play certain content on the user's television set. Additionally, or alternatively, these other options, when selected by a user, may cause the DVR to display a user interface through which the user can actually interact with content, such as an item that was featured or referenced in the television program that the user was just watching.

Abstract: A solid antiperspirant stick composition in the form of a water-in-oil emulsion comprising (i) an aqueous phase comprising dissolved aluminium sesquichlorohydrate antiperspirant active; (ii) an oil phase comprising a solidifying agent; (iii) an emulsifier and (iv) at least 5% by weight of a polyol selected from glycerol, propylene glycol and/or PEG oligomers having a molecular weight of from 180 to 420.

Abstract: The present application discloses proteins or peptides and methods of using such proteins or peptides to evaluate the immune status of a patient. In one embodiment, proteins or peptides may be used to detect endogenous calnexin specific CD4 T cells. In one preferred embodiment, the proteins or peptides may comprise peptide-MHCII tetramers (pMHC tetramers).

Abstract: The invention relates to a deodorant composition in the form of a solid stick comprising: a) from 24 to 55 wt. % of dipropylene glycol; b) from 4 to 8 wt. % of propylene glycol; c) from 10 to 20 wt. % of glycerol; d) from 20 to 40 wt. % of water; and, e) from 0.5 to 15 wt. % of a structurant; wherein, the weight ratio of dipropylene glycol (a), to propylene glycol (b) is greater than 5:1; and, wherein, the weight ratio of dipropylene glycol (a), to glycerol (c) is from 1:1 to 3:1.

Abstract: A Dectin-2 ligand vaccine adjuvant and a method of making and using the Dectin-2 ligand vaccine adjuvant in a vaccine to immunize a patient are disclosed. Also discloses is a vaccine composition comprising a Bl-Eng2 antigen and methods of using the vaccine composition to immunize a subject against a fungal infection.

Abstract: A vaccine comprising Calnexin fragment and a method of using the vaccine to immunize a patient against fungi are disclosed. The Calnexin fragment may be either a full-length native version or a functionally equivalent version of full-length Calnexin.

Abstract: The invention relates to a deodorant composition in the form of a solid stick comprising: a) from 24 to 55 wt. % of dipropylene glycol; b) from 4 to 8 wt. % of propylene glycol; c) from 10 to 20 wt. % of glycerol; d) from 20 to 40 wt. % of water; and, e) from 0.5 to 15 wt. % of a structurant; wherein, the weight ratio of dipropylene glycol (a), to propylene glycol (b) is greater than 5:1; and, wherein, the weight ratio of dipropylene glycol (a), to glycerol (c) is from 1:1 to 3:1.

Abstract: An ultrasonic flow meter for measuring the flow of a fluid includes a transducer assembly having an adjustable length. The transducer assembly is positioned in a transducer port in the meter body and includes a piezoelectric capsule axially positioned adjacent a first end of the transducer assembly. The piezoelectric capsule includes a transformer, a piezoelectric element axially spaced from the transformer, and axially-extendable wireway. A conductor extends through the extendable wireway and electrically couples the piezoelectric element with the transformer.

Abstract: A flowmeter includes an orifice plate assembly having a carrier that includes an aperture, an annular rim disposed about the aperture, and an annular ledge extending radially inward from the rim to the aperture. An orifice plate and annular seal are disposed within the annular rim. The plate engages the ledge and is retained on the carrier by a retaining ring and the energized annular seal. The seal is disposed in a seal gland formed between the orifice plate, the carrier, and the ring member, and sealingly engages at least one surface of each.

Abstract: Disclosed are photoinitiators that are ultra violet (UV) reactive. The photoinitiators can be polymerized into polymeric backbones for use in UV curable hot melt pressure sensitive adhesives. The preferred polymeric backbones are acrylic-based polymers. The photoinitiators are very UVC sensitive and have excellent hot melt viscosity stability that is many fold higher than existing photoinitiators. The subject photoinitiators feature aryl ketones linked through an ether linkage to a variety of connector sequences that allow for polymerization of the photoinitiators.

Abstract: The present application discloses proteins or peptides and methods of using such proteins or peptides to evaluate the immune status of a patient. In one embodiment, proteins or peptides may be used to detect endogenous calnexin specific CD4 T cells. In one preferred embodiment, the proteins or peptides may comprise peptide-MHCII tetramers (pMHC tetramers).

Abstract: The present application discloses proteins or peptides and methods of using such proteins or peptides to evaluate the immune status of a patient. In one embodiment, proteins or peptides may be used to detect endogenous calnexin specific CD4 T cells. In one preferred embodiment, the proteins or peptides may comprise peptide-MHCII tetramers (pMHC tetramers).

Abstract: A flowmeter includes an orifice plate assembly having a carrier that includes an aperture, an annular rim disposed about the aperture, and an annular ledge extending radially inward from the rim to the aperture. An orifice plate and annular seal are disposed within the annular rim. The plate engages the ledge and is retained on the carrier by a retaining ring and the energized annular seal. The seal is disposed in a seal gland formed between the orifice plate, the carrier, and the ring member, and sealingly engages at least one surface of each.

Abstract: An ultrasonic flow meter for measuring the flow of a fluid includes a transducer assembly having an adjustable length. The transducer assembly is positioned in a transducer port in the meter body and includes a piezoelectric capsule axially positioned adjacent a first end of the transducer assembly. The piezoelectric capsule includes a transformer, a piezoelectric element axially spaced from the transformer, and axially-extendable wireway. A conductor extends through the extendable wireway and electrically couples the piezoelectric element with the transformer.

Abstract: A vaccine comprising Calnexin fragment and a method of using the vaccine to immunize a patient against fungi are disclosed. The Calnexin fragment may be either a full-length native version or a functionally equivalent version of full-length Calnexin.

Abstract: A vaccine comprising Calnexin fragment and a method of using the vaccine to immunize a patient against fungi are disclosed. The Calnexin fragment may be either a full-length native version or a functionally equivalent version of full-length Calnexin.

Abstract: A Dectin-2 ligand vaccine adjuvant and a method of making and using the Dectin-2 ligand vaccine adjuvant in a vaccine to immunize a patient are disclosed. Also discloses is a vaccine composition comprising a Bl-Eng2 antigen and methods of using the vaccine composition to immunize a subject against a fungal infection.

Abstract: A method of treating or preventing fungal infection, which includes identifying a plant or animal having a fungal infection and administering an effective amount of an anti-fungal composition to the plant or animal to reduce the fungal infection. In a preferred form of the present invention, the antifungal composition is compound 13 or 33 and is combined with an azole compound, such as fluconazole.